title: Evaluating sepsis during continuous dialysis: are biomarkers still valid?
authors.affiliation: ICU Department, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Honoré
authors.forename: Rita
authors.initials: R
authors.lastname: Jacobs
authors.forename: Elisabeth
authors.initials: E
authors.lastname: De Waele
authors.forename: Viola
authors.initials: V
authors.lastname: Van Gorp
authors.forename: Herbert D
authors.initials: HD
authors.lastname: Spapen
mesh_terms: D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008070:Lipopolysaccharides / Q000302:isolation & purification*; D008297:Male; D011183:Postoperative Complications / Q000097:blood*; D006435:Renal Dialysis / Q000295:instrumentation*; D018805:Sepsis / Q000097:blood* / Q000628:therapy*; D016060:Sorption Detoxification / Q000295:instrumentation*
chemical_list: D008070:Lipopolysaccharides